A dose of private equity is apparently just what the doctor ordered. On Tuesday, UK-based PE firm Vitruvian Partners made a $637 million strategic investment in DeepIntent, a health care-focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback